Thus, the interplay between increasing mechanical forces, agonistic autoantibodies and circulating angiotensin II levels culminate in AT1R-B2R-mediated symptoms of preeclampsia and preeclampsia hypertension at end-stage pregnancy (Figure 3). This evidence concerns the gene AGTR1 and preeclampsia.